Literature DB >> 17498554

Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations.

Ramon Martinez1, Wolfgang Roggendorf, Gustavo Baretton, Rüdiger Klein, Grisha Toedt, Peter Lichter, Gabriele Schackert, Stefan Joos.   

Abstract

We have comparatively analyzed mechanisms associated with chromosomal and microsatellite instability in giant cell glioblastoma multiforme (gcGBM) and classic GBM. This included microsatellite instability (MSI), loss of expression of four major mismatch repair (MMR) proteins, aberrations of five chromosomes, EGFR copy number, and TP53 mutations. MSI was more frequent among gcGBM (30 vs. 7.8%, P = 0.054). TP53 mutations were more commonly observed in gcGBM (83.3%), whereas EGFR was amplified in just one gcGBM (8.3%). By tumor cell phenotype-specific cytogenetic analysis of gcGBM, increased chromosome copy numbers were identified in 72-84% of giant cells but in only 4-14% of nongiant cells; in classic GBM, intermediate frequencies were noted (11-49%). Chromosome 10 deletions were found in nongiant cells of all gcGBM cases but in only approximately 45% of the cell population in classic GBM. The present study shows a distinct pattern of cytogenetic alterations in nongiant and giant cell phenotypes in gcGBM and suggests that multinuclear giant cells evolve from nongiant tumor cells at an early tumor stage. Furthermore, the data point to differences in the profile of chromosomal and microsatellite instability in gcGBM and classic GBM that might underscore the distinct pathological features of both tumor subtypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498554     DOI: 10.1016/j.cancergencyto.2007.01.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.

Authors:  John S Jarboe; Joshua C Anderson; Christine W Duarte; Tapan Mehta; Somaira Nowsheen; Patricia H Hicks; Alexander C Whitley; Timothy D Rohrbach; Raymond O McCubrey; Sherard Chiu; Tamara M Burleson; James A Bonner; G Yancey Gillespie; Eddy S Yang; Christopher D Willey
Journal:  Clin Cancer Res       Date:  2012-05-22       Impact factor: 12.531

2.  Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.

Authors:  Kevin R Kozak; John S Moody
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

3.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

4.  TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.

Authors:  Diana Cantero; Manuela Mollejo; Juan M Sepúlveda; Nicky D'Haene; Myriam J Gutiérrez-Guamán; Ángel Rodríguez de Lope; Concepción Fiaño; Javier S Castresana; Laetitia Lebrun; Juan A Rey; Isabelle Salmon; Bárbara Meléndez; Aurelio Hernández-Laín
Journal:  Neurooncol Adv       Date:  2020-01-24

5.  Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme.

Authors:  Ramon Martinez-Olivera; Angeliki Datsi; Maren Stallkamp; Manfred Köller; Isabelle Kohtz; Bogdan Pintea; Konstantinos Gousias
Journal:  Oncotarget       Date:  2018-09-11

6.  Pediatric Giant Cell Glioblastoma Presenting with Intracranial Dissemination at Diagnosis: A Case Report.

Authors:  Takamasa Kinoshita; Hirohito Yano; Noriyuki Nakayama; Natsuko Suzui; Tomohiro Iida; Saori Endo; Shiho Yasue; Michio Ozeki; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Toru Iwama
Journal:  NMC Case Rep J       Date:  2021-06-05

7.  Giant cells glioblastoma: case report and pathological analysis from this uncommon subtype of glioma.

Authors:  Telmo A B Belsuzarri; João F M Araujo; Aguinaldo P Catanoce; Maick W F Neves; Rodrigo A S Sola; Juliano N Navarro; Leandro G Brito; Nilton R Silva; Luis Otavio C Pontelli; Luiz Gustavo A Mattos; Tiago F Gonçales; Wolnei M Zeviani; Renata M B Marques
Journal:  Rare Tumors       Date:  2015-03-26

8.  IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.

Authors:  Valeria Barresi; Michele Simbolo; Andrea Mafficini; Maurizio Martini; Martina Calicchia; Maria Liliana Piredda; Chiara Ciaparrone; Giada Bonizzato; Serena Ammendola; Maria Caffo; Giampietro Pinna; Francesco Sala; Rita Teresa Lawlor; Claudio Ghimenton; Aldo Scarpa
Journal:  Acta Neuropathol Commun       Date:  2021-12-24       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.